Reference lab Quest Diagnostics (NYSE:DGX) says its test service
for COVID-19 will be available on Monday, March 9. It is a
laboratory-developed test that is pending review by the FDA under its
Emergency Use Authorization provision.
The molecular diagnostic assay detects viral RNA in respiratory specimens.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.